Showing results (1901-1910 of 1,998) with videos related to

Sort By:
Pageof 200
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 3, 2021
International Medullary Thyroid Carcinoma Grading System: A Validated Grading System for Medullary Thyroid CarcinomaBin Xu, Talia L Fuchs, Sara Ahmadi, et al.
Molecular Cancer Research : MCR|December 4, 2015
Cancer-Associated Fibroblasts Induce a Collagen Cross-link Switch in Tumor StromaDaniela Pankova, Yulong Chen, Masahiko Terajima, et al.
The British Journal of Surgery|November 4, 2022
Histopathological tumour response scoring in resected pancreatic cancer following neoadjuvant therapy: international interobserver study (ISGPP-1)Boris V Janssen, Stijn van Roessel, Susan van Dieren, et al.
Genome Medicine|April 30, 2017
Lost in translation: returning germline genetic results in genome-scale cancer researchAmber L Johns, Skye H McKay, Jeremy L Humphris, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 18, 2025
Risk of hepatocellular carcinoma after direct-acting antiviral treatment for hepatitis C virus infection in people with HIVDaniela K van Santen, Mathieu Chalouni, Juan Berenguer, et al.
Oncogene|June 21, 2026
HSP47 is a potential dual cell target and prognostic factor in pancreatic cancerGeorge Sharbeen, Estrella Gonzales-Aloy, Janet Youkhana, et al.
Bioorganic & Medicinal Chemistry Letters|November 7, 2020
Ibrexafungerp: An orally active β-1,3-glucan synthesis inhibitorJames M Apgar, Robert R Wilkening, Dann L Parker, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 22, 2015
Precision Medicine for Advanced Pancreas Cancer: The Individualized Molecular Pancreatic Cancer Therapy (IMPaCT) TrialLorraine A Chantrill, Adnan M Nagrial, Clare Watson, et al.
Jac-Antimicrobial Resistance|July 5, 2021
Feasibility study of hospital antimicrobial stewardship analytics using electronic health recordsP F Dutey-Magni, M J Gill, D McNulty, et al.
Bioorganic & Medicinal Chemistry Letters|August 3, 2020
MK-5204: An orally active β-1,3-glucan synthesis inhibitorJames M Apgar, Robert R Wilkening, Dann L Parker, et al.
Pageof 200